drugset / Trial / NCT03599596

Monthly Versus Two Doses of Ante-Natal Intermittent Preventive Treatment With Sulphadoxine-Pyrimethamine

NCT03599596

Phase 1 Unknown 136 enrolled University College Hospital, Ibadan
RandomizedParallel-groupSingle-blindPrevention

Summary

Randomized controlled prospective comparative study

Timeline

Start
2018-09-01
Primary completion
2018-12-01
Completion
2019-02-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator pyrimethamine Small molecule 25 mg
Comparator sulfadoxine Small molecule 500 mg

Indications